SK Life Sciences has Licensed Pristima
Xybion Medical Systems, is pleased to announce that SK Life Science, Inc. (SKLSI), has
licensed Pristima for its Research and Development facility in Fair Lawn, New Jersey.
Cedar Knolls, NJ (PRWEB) August 3, 2009 -- Xybion Medical Systems, a world leader in toxicology a...
MIT is pleased to announce that it has received a US$ 500,000 private placement from its Chinese partners
DENVER, CO, June 25 /PRNewswire-FirstCall/ - Medical International Technology Inc. (MDLH. PK) ( http://www.mitcanada.ca http://www.mitinvest.ca ), MIT is pleased to announce that it has
received a US$ 500,000 private placement from its Chinese partners and a new order of 200 units. This privat...
Wound Management Technologies, Inc. Announced Today That It Has Reached an Agreement in Principal to Acquire BioPharma Management Technologies, Inc.
FORT WORTH, Texas, June 16 /PRNewswire/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (WNDM.OB), announced today that it has
reached an agreement in principle to acquire BioPharma Management Technologies, Inc., a privately held biotechnology company with a pl...
New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease
COLLEGEVILLE, Pa., June 11 /PRNewswire-FirstCall/ -- New data from Phase 3 European clinical trials reinforce that Wyeth's (NYSE: WYE ) investigational pneumococcal vaccine, Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine, 13-valent [Adsorbed]), has
the potential to provide cov...
Techne Corporation Announces That John L. Higgins has Accepted a Seat on Techne's Board
MINNEAPOLIS, May 19 /PRNewswire-FirstCall/ -- Techne Corporation (Nasdaq: TECH ) today announced that Mr. John L. Higgins has
accepted a position on Techne's Board of Directors and will also serve as a member of Techne's Audit, Compensation and Nominations and Governance Committees. Mr. Higgins...
The Concerned Shareholders of Biovail Say Biovail Has Misled Shareholders
Shareholders are Urged to Vote their YELLOW proxy, FOR the Election of
Two Highly Qualified and Independent Directors to the Biovail Board
TORONTO, May 15 /PRNewswire/ - The Concerned Shareholders of Biovail today said that Biovail Corporation (NYSE: BVF ) (TSX:BVF) continues to mi...
Yongye Biotechnology Distributor has Record Breaking Single Store Sales Day
BEIJING, May 1 /PRNewswire-Asia/ -- Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB; "Yongye" or the "Company"), a leading distributor of plant and animal nutrient products located in the People's Republic of China, today announced that one of the independently owned Yongye bran...
FDA has Granted HUD (Humanitarian Use Device) Designation to ITGI's Pericardium Covered Stents, Over and Under(R) and Aneugraft(R), for Treatment of Perforations and Dissections of Native Coronary Arteries and Saphenous Vein Grafts
OR AKIVA, Israel, April 28 /PRNewswire-FirstCall/ -- ITGI Medical, Ltd.
(TASE: ITGI) a company engaged in research, development, manufacturing and
marketing of heterologous tissue covered stents, announced that the US Food
and Drug Administration (FDA) has
granted HUD (Humanitarian Use Device)...
The NIHR Biomedical Research Centre for Mental Health London has Joined the MetaMiner CNS Partnership Program
ST. JOSEPH, Mich., March 24 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that the NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and King's College London (BRC-MH), has
joined the MetaMiner CNS Par...
Monsanto's Historic R&D Investment has Contributed to Mid-20s Gross Profit Growth for Its Seeds and Genomics Segment
Drought-Tolerance Technology Crosses Another Key Regulatory Milestone
LONDON, March 10 /PRNewswire-FirstCall/ -- Monsanto's historic investment in research and development in breeding and biotechnology has
contributed to a 24 percent compound annual growth rate for the company's Seeds and G...
Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE(R) With the FDA After Successful End of Phase II Meeting
KVISTGAARD, Denmark, March 3 /PRNewswire-FirstCall/ -- Following the
completion of the Phase II clinical development of IMVAMUNE(R), a
third-generation smallpox vaccine, Bavarian Nordic has
held an end of Phase
II meeting with the FDA to discuss the Phase III development. The meeting was
Sigma-Aldrich (NASDAQ:SIAL) Announces it Has Filed Its December 31, 2008 Form 10-K
ST. LOUIS, Feb. 27 /PRNewswire-FirstCall/ -- A copy of the Company's December 31, 2008 Form 10-K, as filed with the Securities & Exchange Commission, may be obtained without charge at our website address, www.sigma-aldrich.com , or upon writing to the Secretary, Sigma-Aldrich Corporation, P. ...
Accidental discovery has potential for new applications in packaging
CLEVELAND A recent discovery at Case Western Reserve University may help keep food and drugs safer and fresher longer and electronic equipment dryer and more secure than ever before all at a lower cost.
The finding involves a nanotechnology-based technique to block the transport of damaging g...
Novel Diabetes Drug Discovery Has Potential to Reverse Disease
WYNNEWOOD, Pa., Jan. 27 /PRNewswire/ -- A study released today in Endocrine Practice (2008;14:1075), the leading peer-reviewed journal for practicing endocrinologists in the US and 65 countries, reports a ground breaking discovery with the potential to reverse type 1 and 2 diabetes. Scientists ...
Rising H9N2 Influenza Replikin Count Has Doubled That of H5N1
The H9N2 strain of influenza commonly infects poultry and occasionally humans. Replikins, Ltd., using its FluForecast® software, has
studied the Replikin Count® annually in each of H9N2 and its sister strain H5N1. Cyclic increases and decreases appear to be synchronous for H9N2 and H5N1...
NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections
NEW YORK, Dec. 4 /PRNewswire-FirstCall/ -- NeoStem, Inc.
(NYSE Alternext US: NBS), which is pioneering the pre-disease collection,
processing and long-term storage of adult stem cells for future medical need,
today announced that it has
reached a major milestone in its current business
plan with t...
Keryx Biopharmaceuticals Notified that Nasdaq Has Extended Minimum Bid Price Rule Compliance Period
NEW YORK, Oct. 23 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals,
Inc. (Nasdaq: KERX ) announced today that it has
received notice from The
Nasdaq Stock Market ("Nasdaq") stating that Nasdaq Marketplace Rule
4310(c)(4), which requires companies to maintain a minimum bid price of
CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team
ORLANDO, Fla., Oct. 14 /PRNewswire/ -- Dr. Eliane Gluckman, recognized
as a pioneer and leader in the field of cord blood stem cell
joined the team at CORD:USE Cord Blood Bank. "We are
honored to have such an accomplished physician as Dr. Gluckman join our
team of highly e...
Arbios Announces It Has Suspended Operations
Action taken to conserve cash while seeking financing/strategic alternatives
WALTHAM, Mass., Aug. 5 /PRNewswire-FirstCall/ -- Arbios Systems, Inc.
(OTC Bulletin Board: ABOS) announced today that the Company is focusing its
day-to-day operations exclusively on o...
Arbel Medical has Completed a $4.5 million Round of Capital Raising led by Giza Venture Capital Fund
YOKNEAM, Israel, July 17 /PRNewswire/ -- Arbel Medical, an Israeli
start-up developing the next generation of medical equipment for removing
tumors by freezing (cryotherapy), has
completed raising $4.5 million of
capital in its second round, led by the Giza Venture Capital fund.
The Docor In...
World Chemical Industry Has Decided to Gather at ChemOutsourcing Show on September 7-9 in New Jersey
LONG BRANCH, N.J., July 8 /PRNewswire/ -- The world chemical and
pharmaceutical industries are slated to gather in New Jersey in early
September to attend the Pharma ChemOutsourcing show. The annual fine and
custom chemicals sourcing event is geared to top pharmaceutical and
Access Pharmaceuticals Presents New Data at International Symposium Showing Company's Angiolix(R) Monoclonal Antibody has Potential to Treat Cancer by Attacking Cancer Stem Cells
DALLAS, June 26 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC.
(OTC Bulletin Board: ACCP) announced that the Company gave an oral
presentation yesterday on its monoclonal antibody product, Angiolix(R), at
the 7th International Congress on Recombinant Antibodies, held in Dublin,
Awareness of Genzyme's Renvela(R) (Sevelamer Carbonate) is High, Although Uptake of this New Phosphate Binding Agent has Been Slower than Nephrologists and Renal Dietitians Initially Expected
EXTON, Pa., May 23 /PRNewswire/ -- BioTrends Research Group, Inc.
released Wave 1 of its LaunchTrends(TM): Renvela report, the second in a
multi-phase syndicated market research project tracking the launch of
Renvela from baseline awareness through the first six months of product
Nebulized Formoterol Fumarate Has Comparable Pharmacokinetic and Pharmacodynamic Profile to Dry Powder Formulation
- Data from two clinical trials presented at International ATS Conference -
NAPA, Calif., May 20 /PRNewswire/ -- Data presented today at the
International Conference of the American Thoracic Society (ATS) demonstrate
that Perforomist(TM) Inhalation Solution (formoterol fumarate inhalation
Avastin Used in Combination with Drugs from Bristol-Myers Squibb Has Advantages in Survival Rates Over the Current Sales-Leading Therapy for Advanced Ovarian Cancer
Avastin Used in Combination with Taxol and Paraplatin Will Become the
Clinical Gold Standard Treatment by 2011, According to a New Report from Decision Resources
WALTHAM, Mass., April 23 /PRNewswire/ -- Decision Resources, one of the
world's leading research and ad...
eBioscience Corporation Announced Today That James Glynn Has Been Appointed to Its Board of Directors, Effective April 15, 2008
SAN DIEGO, April 15 /PRNewswire/ -- Mr. Glynn has
over 34 years of
combined financial, operating and director level experience, and is well
known within the life sciences industry for his role in the growth and
development of several biotechnology companies. Most notably, Mr. Glynn
Nanosized technology has supersized effect on tumors
Anyone facing chemotherapy would welcome an advance promising to dramatically reduce their dose of these often harsh drugs. Using nanotechnology, researchers at Washington University School of Medicine in St. Louis have taken a step closer to that goal.
The researchers focused a powerful drug d...
China Biologic Products Announces One of Its R&D Projects Has Been Listed In National Torch Plan
TAIAN CITY, China, March 25 /Xinhua-PRNewswire-FirstCall/ -- China
Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or "the
Company"), one of the leading plasma-based pharmaceutical companies in the
People's Republic of China ("PRC"), today announced that one of its R&D
AMEX Notifies Signalife That It Has Accepted Signalife's Plan of Compliance
GREENVILLE, S.C., March 20 /PRNewswire-FirstCall/ -- On January 7,
2008, Signalife received a deficiency letter from the American Stock
Exchange ("AMEX") pursuant to which it advised that Signalife would need to
comply with the $6 million stockholders' equity threshold required for
USANA's CEO Myron W. Wentz, Ph.D. Has Been Elected to Serve on Immunosyn Corporation's Board of Directors
LA JOLLA, Calif., March 17 /PRNewswire-FirstCall/ -- Immunosyn
Corporation (OTC Bulletin Board: IMYN) is pleased to announce that Myron W.
Wentz, Ph.D., Chief Executive Officer and Chairman of the Board of USANA
Health Sciences, Incorporated (Nasdaq: USNA ), was elected to serve as a
National Stem Cell Holding, Inc. Has Engaged BMA Securities to Assist and Advise the Company With Its Current Capital Raise of $3,500,000
MOUNTAINSIDE, N.J., Feb. 19 /PRNewswire-FirstCall/ -- National Stem
Cell Holding, Inc. (OTC: NHGI) today announced the engagement of Burt
Martin Arnold Securities, Inc. ("BMA Securities") to provide advisory and
investment banking services with respect to assisting and advising the
Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility
QINGDAO, China, Feb. 14 /Xinhua-PRNewswire/ -- Shenzhen Beike
Biotechnology Co., Ltd. ( http://www.beikebiotech.com ), the world leader
in the use of umbilical cord stem cells to successfully treat a variety of
illnesses, announced that Audrey Jones, the former Lord Mayor of
A researcher of UPV/EHU has designed nanomagnets for industry
The PhD, defended by chemist Sonia Moralejo Garca at the University of the Basque Country (UPV/EHU), achieved a well-defined line for the manufacture of nanomagnets and other magnetic devices of wide industrial application.
It is well known that current technology tends to design tools that are...
The Jordan Company, L.P. Has Teamed with the Management of Haas TCM Inc. to Form Haas TCM Group Inc.
NEW YORK, Jan. 11 /PRNewswire/ -- "I am pleased to announce that Haas
TCM Inc. and its subsidiaries, Kemfast Aerospace Group, Ltd. and Kemfast,
Ltd (collectively Kemfast) and its MC Technologies division have combined
with an affiliate of The Jordan Company, L.P. to form Haas TCM Group Inc.
National Stem Cell Holding, Inc. Posts Company and Financial Information on the OTCIQ and Has Retained New CFO and Counsel to File Registration Statement With SEC
MOUNTAINSIDE, N.J., Dec. 17 /PRNewswire-FirstCall/ -- National Stem
Cell Holding, Inc. (Other OTC: NHGI) today announced that its company
information, financial information, quotations and press releases are
posted on the OTCIQ, a service of the Pink Sheets.
OTCIQ is a secure, web-based port...
Elbit Medical Imaging Ltd. Announces that Plaza Centers Has Entered into a Joint Venture Partnership to Develop Residential and Office Projects in Romania
TEL-AVIV, Oct. 23 /PRNewswire-FirstCall/ -- Elbit Medical Imaging Ltd.
(TASE, Nasdaq: EMITF) ("EMI" or the "Company") announced today that its
subsidiary, Plaza Centers N.V. (LSE: PLAZ) ("Plaza"), a leading Central and
Eastern European ("CEE") and in India emerging markets property developer,
Agendia BV Announces That its Chief Research Officer Laura van 't Veer has Received a 2007 Breast Cancer Research Foundation Award
AMSTERDAM, The Netherlands, October 22 /PRNewswire/ -- Agendia BV, a
world leader in the rapidly evolving field of cancer molecular diagnostics,
announced today that its Chief Research Officer Laura van 't Veer has
received a prestigious 2007 Breast Cancer Research Foundation Award from
SALVAT has Completed Patient Enrollment in a Dose Finding Phase II Trial of SVT-40776 for the Treatment of Overactive Bladder
Results Expected to be Delivered by November 2007
BARCELONA, Spain, October 9 /PRNewswire/ -- This double-blind,
placebo-controlled and multi-center Phase II trial includes 332 patients
with Overactive Bladder (OAB) and has
been conducted at 77 sites in 11
countries (US, Germany, Sp...
European Union has 'Three-Speed' Healthcare System - Many Countries Lagging in Reform
BRUSSELS, October 1 /PRNewswire/ -- Austria now has
consumer-friendly healthcare system in Europe, according to the 2007 Euro
Health Consumer Index (EHCI). The EHCI compares all the EU 27 national
healthcare systems, along with Norway and Switzerland, from a
consumer-friendly point of...
ThalesNano Inc. Opens Own Representation in the United Kingdom and has New Distribution Agreements for Europe and India
BUDAPEST, Hungary, September 24 /PRNewswire/ -- ThalesNano Inc., a
leading developer and manufacturer of flow chemistry, flow reactor
technology, and hydrogenation technology solutions, announced today that it
had continued to expand globally by opening a subsidiary in the United
Kingdom and b...